Cancer M.D.'s clash over interleukin therapy.
D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2